2 results match your criteria: "Second Department of Internal Medicine Gifu University Graduate School of Medicine[Affiliation]"
Article Synopsis
- Antibodies targeting the PD-1 receptor on T cells, like nivolumab, are now used to treat lung cancer but come with risks of immune-related side effects.
- A case study of a 77-year-old man illustrates that nivolumab can induce thrombocytopenia (low platelet count) after mild fever, despite no signs of serious underlying conditions.
- Treatment with prednisolone successfully restored platelet counts and led to tumor shrinkage, emphasizing the need for awareness of rare side effects associated with immune checkpoint inhibitors.
The purpose of this study was to assess the effect on bone mineral density (BMD) of systemic corticosteroid (SCS) intermittently administered for rescue from asthmatic exacerbation. Through digital image processing and calculation of four other indices, BMD was compared in groups of asthmatic patients receiving inhaled corticosteroid (ICS) alone or ICS plus intermittent SCS. We defined SCS as intermittent administration of the equivalent of 1 mg/day prednisolone in the management of asthma exacerbations during the previous 1 year.
View Article and Find Full Text PDF